NET PROFIT (x1000 SEK)
EMPLOYEES
Acadia Pharmaceuticals A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-225
|
-380
|
-29 |
| Total assets |
4
|
7
|
8 |
| Current assets |
4
|
7
|
8 |
| Current liabilities |
1,483
|
1,266
|
817 |
| Equity capital |
-1,478
|
-1,259
|
-809 |
| - share capital |
895
|
899
|
827 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
-36950.0%
|
-17985.7%
|
-10112.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
0.3%
|
0.6%
|
1.0% |
| Return on equity (ROE) |
15.2%
|
30.2%
|
3.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.